Table 1.
Summary of percent radioactivity recovered in urine and feces from healthy male human subjects after a single oral 20-mg (80-μCi) suspension dose of [14C]dolutegravir
| Subject | % of administered dose |
||
|---|---|---|---|
| Feces | Urine | Total | |
| 531001 | 72.0 | 24.0 | 96.1 |
| 531002 | 65.2 | 30.6 | 95.8 |
| 531003 | 61.0 | 34.8 | 95.8 |
| 531004 | 59.4 | 33.8 | 93.2 |
| 531005 | 65.7 | 29.4 | 95.1 |
| 531006a | 60.8 | 36.7 | 97.6 |
| Mean | 64.0 | 31.6 | 95.6 |
| SD | 4.7 | 4.6 | 1.4 |
a
Subject 531006 withdrew from the study after 144 h postdose. The subject was excluded from descriptive statistics after this time point.